Searches , social queries for NEUROPHYSIN II
Search references for NEUROPHYSIN II. Phrases containing NEUROPHYSIN II
See searches and references containing NEUROPHYSIN II!
Search references for NEUROPHYSIN II. Phrases containing NEUROPHYSIN II
See searches and references containing NEUROPHYSIN II!NEUROPHYSIN II
Cleavage product of the arginine vasopressin gene
Neurophysin II is a carrier protein with a size of 19,687.3 Da and is made up of a dimer of two virtually identical chains of amino acids. Neurophysin
Neurophysin_II
Carrier protein for oxytocin and vasopressin
neurosecretory granules, the analogous neurophysin I and II form stabilizing complexes via covalent interactions. Stabilizing neurophysin-hormone complexes that are
Neurophysins
Cleavage product of the coding protein of OXT gene
Neurophysin I is a carrier protein with a size of 10 KDa and contains 90 to 97 amino acids. It is a cleavage product (formed by splitting of a compound
Neurophysin_I
Structures in the pituitary gland
contains ATP and a type of neurophysin. Neurophysins are binding proteins, of which there are two types: neurophysin I and neurophysin II, which bind to oxytocin
Herring_bodies
Peptide hormone and neuropeptide
"Linkage relationships of human arginine vasopressin-neurophysin-II and oxytocin-neurophysin-I to prodynorphin and other loci on chromosome 20". Molecular
Oxytocin
Protein fragment in Homo sapiens
derived from the C-terminus of pre-pro-hormone of arginine vasopressin, neurophysin II and copeptin. Arginine vasopressin (AVP), also known as the antidiuretic
Copeptin
Mammalian hormone released from the pituitary gland
calcium channels in neurohypophyseal nerve terminals in rats. Angiotensin II stimulates AVP secretion, in keeping with its general pressor and pro-volumic
Vasopressin
Gene
to produce vasopressin (also known as antidiuretic hormone or ADH), neurophysin II, and a glycoprotein called copeptin. AVP and other AVP-like peptides
AVP_gene
Chemical substance that enables neurotransmission
type II synapses are flattened. The material on the presynaptic and post-synaptic membranes is denser in a Type I synapse than it is in a Type II, and
Neurotransmitter
Chemical compound
synthesized as a preprohormone that includes a second peptide, neurophysin VT (neurophysins are carrier proteins that are secreted along with their passenger
Vasotocin
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
NP-1031
Release of milk from the mammary glands
hypothalamo-neurohypophyseal tract with the help of the carrier protein, neurophysin I, to the pars nervosa of the posterior pituitary, and then stored in
Lactation
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
CA7_(drug)
Chemical compound
Omeclamox, and Ethyol. Hepatoren, Boxban, Vasculan, and currently in phase II clinical trials. Protaban, Methotrexate, and Totect are waiting for pre-approval
Conivaptan
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Demoxytocin
American biochemist
Biology. Through his research, Sachs discovered the relationship between neurophysin, an intracellular chaperone protein and vasopressin, the neurohormone
Howard_Sachs_(scientist)
Chemical compound
mothers with lactation failure requiring lactation support, and is in phase II clinical trials for this indication. Merotocin is potent (EC50 < 0.1 nM) and
Merotocin
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
TGOT
Protein-coding gene in the species Homo sapiens
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Vasopressin_receptor_1B
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Retosiban
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Relcovaptan
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Felypressin
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Epelsiban
Chemical compound
derivative, and was developed from LY-307174 as a lead compound. A Phase II activity trial of the drug in the treatment of adults with intermittent explosive
SRX246
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Oxytocin_receptor_agonist
Medication
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Desmopressin
Oxytocin receptor antagonist
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Tocinoic_acid
G protein-coupled receptor
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Vasopressin_receptor
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Lithium_carbonate
Protein-coding gene in the species Homo sapiens
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Vasopressin_receptor_2
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
L-368,899
Estrogen medication
Robinson AG (May 1981). "Oxytocin in human plasma: correlation with neurophysin and stimulation with estrogen". J Clin Endocrinol Metab. 52 (5): 988–993
Ethinylestradiol
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Demeclocycline
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Nelivaptan
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
NMRA-511
Agent that interferes with action at the vasopressin receptors
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Vasopressin receptor antagonist
Vasopressin_receptor_antagonist
Small-molecule oxytocin receptor agonist
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
LIT-001
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Selepressin
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
SRX251
125.825.249 – synaptotagmin i MeSH D12.776.157.125.825.500 – synaptotagmin ii MeSH D12.776.157.325.150.200 – peptide elongation factor g MeSH D12.776.157
List of MeSH codes (D12.776.157)
List_of_MeSH_codes_(D12.776.157)
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
NTX-1472
Medication used for preventing postpartum bleeding
"Neurohypofyzární peptidy v lékařství z pražských a švédských laboratoří. Část II: desmopressin, terlipressin, carbetocin – farmakologie a klinické aplikace"
Carbetocin
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
LIT-002
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Nolasiban
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Atosiban
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
TC_OT_39
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Tolvaptan
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
PF-06655075
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Vasopressin_(medication)
Medication made from the peptide oxytocin
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Oxytocin_(medication)
Vasopressin V1A receptor antagonist
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
RG7713
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Cligosiban
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
KNX-101
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
OT-12
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
KNX-100
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Terlipressin
Medication causing uterine contraction
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Uterotonic
Protein-coding gene in the species Homo sapiens
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Vasopressin_receptor_1A
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
WAY-267464
Genes on human chromosome 3
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Oxytocin_receptor
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Satavaptan
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
PF-184563
Chemical compound
treatment of major depressive disorder. As of November 2022, it is in phase II clinical trials for this indication. ABT-436 Balovaptan List of investigational
Brezivaptan
Pharmaceutical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
WJ0679
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Mozavaptan
Chemical compound
hyponatremia indications is no longer ongoing. Palladio conducted the ELiSA Phase II study with lixivaptan in 31 ADPKD patients. In this study, the proportion
Lixivaptan
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Lipo-oxytocin-1
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Ornipressin
Chemical compound
disorder (PTSD). It was in a phase III clinical trial for adults and a phase II clinical trial for children for post-traumatic stress disorder. In January
Balovaptan
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
L-371,257
Chemical compound
anxiety disorders, and alcoholism but was discontinued. It reached phase II clinical trials prior to the discontinuation of its development. Balovaptan
ABT-436
Chemical compound
RWJ-339489 VMAX-367 VMAX-372 VMAX-382 YM-222546 Other inhibitors: Demeclocycline Lithium (lithium carbonate) Others Carrier proteins: Neurophysin (I, II)
Barusiban
641.650.070.075 – angiotensin i MeSH D12.776.641.650.070.078 – angiotensin ii MeSH D12.776.641.650.070.080 – angiotensin iii MeSH D12.776.641.650.340.500
List of MeSH codes (D12.776.641)
List_of_MeSH_codes_(D12.776.641)
hormone MeSH D12.644.400.500 – neuropeptide y MeSH D12.644.400.525 – neurophysins MeSH D12.644.400.550 – neurotensin MeSH D12.644.400.575 – opioid peptides
List_of_MeSH_codes_(D12.644)
travel, tourism, insurance
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
NEUROPHYSIN II
travel, tourism, insurance